Loading…
Screening for thyroid disorders during pregnancy: Results of a survey in Maine
Guidelines regarding prenatal screening for thyroid deficiency are conflicting, and current practice in primary care settings is unknown. Our survey sought to determine the: 1) extent of screening in Maine; 2) factors associated with screening; and 3) laboratory cut-off levels used. In 2004 we surve...
Saved in:
Published in: | American journal of obstetrics and gynecology 2006-02, Vol.194 (2), p.471-474 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c384t-8dcd0680716347509fb79fa6563fca2dd00bc36276b59eb8aeac1fc2ebaaad7c3 |
---|---|
cites | cdi_FETCH-LOGICAL-c384t-8dcd0680716347509fb79fa6563fca2dd00bc36276b59eb8aeac1fc2ebaaad7c3 |
container_end_page | 474 |
container_issue | 2 |
container_start_page | 471 |
container_title | American journal of obstetrics and gynecology |
container_volume | 194 |
creator | Haddow, James E. McClain, Monica R. Palomaki, Glenn E. Kloza, Edward M. Williams, Josephine |
description | Guidelines regarding prenatal screening for thyroid deficiency are conflicting, and current practice in primary care settings is unknown. Our survey sought to determine the: 1) extent of screening in Maine; 2) factors associated with screening; and 3) laboratory cut-off levels used.
In 2004 we surveyed 61 prenatal care practices, representing 246 practitioners and 85% of Maine deliveries.
Screening via thyroid-stimulating hormone (TSH) testing was routine in 48% of the practices. Obstetrician practices screened at a significantly higher rate than family practices (56% vs 8%; odds ratio [OR] 15.0, 95% CI 1.9-130.0). Nonsignificant higher rates were found for urban versus rural, and multipractitioner versus solo practices. The lower TSH cut-off levels ranged between 0.1 and 0.5 mU/L among practices; the upper cut-off levels ranged between 3.5 and 5.5 mU/L.
Prenatal screening for thyroid deficiency varies among practices, reflecting conflicting guidelines. TSH cut-offs are also variable and might benefit from standardization. |
doi_str_mv | 10.1016/j.ajog.2005.07.055 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67634877</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002937805011397</els_id><sourcerecordid>67634877</sourcerecordid><originalsourceid>FETCH-LOGICAL-c384t-8dcd0680716347509fb79fa6563fca2dd00bc36276b59eb8aeac1fc2ebaaad7c3</originalsourceid><addsrcrecordid>eNp9kE1LxDAQhoMouq7-AQ-Si95ap-02ScWLiF_gB_hxDmkyWbN0mzVphf33tuyCN0_DMM-8zDyEnGSQZpCxi0WqFn6e5gBlCjyFstwhkwwqnjDBxC6ZAECeVAUXB-QwxsXY5lW-Tw4yNisFm4kJeXnXAbF17ZxaH2j3tQ7eGWpc9MFgiNT0YRyuAs5b1er1JX3D2DddpN5SRWMffnBNXUuflWvxiOxZ1UQ83tYp-by7_bh5SJ5e7x9vrp8SXYhZlwijDTABPGPFjJdQ2ZpXVrGSFVar3BiAWhcs56wuK6yFQqUzq3OslVKG62JKzje5q-C_e4ydXLqosWlUi76PkvEhWHA-gPkG1MHHGNDKVXBLFdYyAzlalAs5WpSjRQlcDhaHpdNtel8v0fytbLUNwNkWUFGrxobBjIt_3PjSeMKUXG04HFz8OAwyaoetRuMC6k4a7_674xcSr5Fw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67634877</pqid></control><display><type>article</type><title>Screening for thyroid disorders during pregnancy: Results of a survey in Maine</title><source>ScienceDirect Journals</source><creator>Haddow, James E. ; McClain, Monica R. ; Palomaki, Glenn E. ; Kloza, Edward M. ; Williams, Josephine</creator><creatorcontrib>Haddow, James E. ; McClain, Monica R. ; Palomaki, Glenn E. ; Kloza, Edward M. ; Williams, Josephine</creatorcontrib><description>Guidelines regarding prenatal screening for thyroid deficiency are conflicting, and current practice in primary care settings is unknown. Our survey sought to determine the: 1) extent of screening in Maine; 2) factors associated with screening; and 3) laboratory cut-off levels used.
In 2004 we surveyed 61 prenatal care practices, representing 246 practitioners and 85% of Maine deliveries.
Screening via thyroid-stimulating hormone (TSH) testing was routine in 48% of the practices. Obstetrician practices screened at a significantly higher rate than family practices (56% vs 8%; odds ratio [OR] 15.0, 95% CI 1.9-130.0). Nonsignificant higher rates were found for urban versus rural, and multipractitioner versus solo practices. The lower TSH cut-off levels ranged between 0.1 and 0.5 mU/L among practices; the upper cut-off levels ranged between 3.5 and 5.5 mU/L.
Prenatal screening for thyroid deficiency varies among practices, reflecting conflicting guidelines. TSH cut-offs are also variable and might benefit from standardization.</description><identifier>ISSN: 0002-9378</identifier><identifier>EISSN: 1097-6868</identifier><identifier>DOI: 10.1016/j.ajog.2005.07.055</identifier><identifier>PMID: 16458648</identifier><identifier>CODEN: AJOGAH</identifier><language>eng</language><publisher>Philadelphia, PA: Mosby, Inc</publisher><subject>Biological and medical sciences ; Endocrinopathies ; Family Practice - statistics & numerical data ; Female ; Gynecology. Andrology. Obstetrics ; Health Care Surveys ; Humans ; Maine ; Mass Screening - utilization ; Medical sciences ; Non tumoral diseases. Target tissue resistance. Benign neoplasms ; Obstetrics - statistics & numerical data ; Practice Patterns, Physicians ; Pregnancy ; Pregnancy Complications - diagnosis ; Prenatal Care - statistics & numerical data ; Reference ranges ; Reference Values ; Thyroid Diseases - diagnosis ; Thyroid testing ; Thyroid. Thyroid axis (diseases) ; Thyrotropin - blood ; TSH</subject><ispartof>American journal of obstetrics and gynecology, 2006-02, Vol.194 (2), p.471-474</ispartof><rights>2006 Mosby, Inc.</rights><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c384t-8dcd0680716347509fb79fa6563fca2dd00bc36276b59eb8aeac1fc2ebaaad7c3</citedby><cites>FETCH-LOGICAL-c384t-8dcd0680716347509fb79fa6563fca2dd00bc36276b59eb8aeac1fc2ebaaad7c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17509676$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16458648$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Haddow, James E.</creatorcontrib><creatorcontrib>McClain, Monica R.</creatorcontrib><creatorcontrib>Palomaki, Glenn E.</creatorcontrib><creatorcontrib>Kloza, Edward M.</creatorcontrib><creatorcontrib>Williams, Josephine</creatorcontrib><title>Screening for thyroid disorders during pregnancy: Results of a survey in Maine</title><title>American journal of obstetrics and gynecology</title><addtitle>Am J Obstet Gynecol</addtitle><description>Guidelines regarding prenatal screening for thyroid deficiency are conflicting, and current practice in primary care settings is unknown. Our survey sought to determine the: 1) extent of screening in Maine; 2) factors associated with screening; and 3) laboratory cut-off levels used.
In 2004 we surveyed 61 prenatal care practices, representing 246 practitioners and 85% of Maine deliveries.
Screening via thyroid-stimulating hormone (TSH) testing was routine in 48% of the practices. Obstetrician practices screened at a significantly higher rate than family practices (56% vs 8%; odds ratio [OR] 15.0, 95% CI 1.9-130.0). Nonsignificant higher rates were found for urban versus rural, and multipractitioner versus solo practices. The lower TSH cut-off levels ranged between 0.1 and 0.5 mU/L among practices; the upper cut-off levels ranged between 3.5 and 5.5 mU/L.
Prenatal screening for thyroid deficiency varies among practices, reflecting conflicting guidelines. TSH cut-offs are also variable and might benefit from standardization.</description><subject>Biological and medical sciences</subject><subject>Endocrinopathies</subject><subject>Family Practice - statistics & numerical data</subject><subject>Female</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Health Care Surveys</subject><subject>Humans</subject><subject>Maine</subject><subject>Mass Screening - utilization</subject><subject>Medical sciences</subject><subject>Non tumoral diseases. Target tissue resistance. Benign neoplasms</subject><subject>Obstetrics - statistics & numerical data</subject><subject>Practice Patterns, Physicians</subject><subject>Pregnancy</subject><subject>Pregnancy Complications - diagnosis</subject><subject>Prenatal Care - statistics & numerical data</subject><subject>Reference ranges</subject><subject>Reference Values</subject><subject>Thyroid Diseases - diagnosis</subject><subject>Thyroid testing</subject><subject>Thyroid. Thyroid axis (diseases)</subject><subject>Thyrotropin - blood</subject><subject>TSH</subject><issn>0002-9378</issn><issn>1097-6868</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNp9kE1LxDAQhoMouq7-AQ-Si95ap-02ScWLiF_gB_hxDmkyWbN0mzVphf33tuyCN0_DMM-8zDyEnGSQZpCxi0WqFn6e5gBlCjyFstwhkwwqnjDBxC6ZAECeVAUXB-QwxsXY5lW-Tw4yNisFm4kJeXnXAbF17ZxaH2j3tQ7eGWpc9MFgiNT0YRyuAs5b1er1JX3D2DddpN5SRWMffnBNXUuflWvxiOxZ1UQ83tYp-by7_bh5SJ5e7x9vrp8SXYhZlwijDTABPGPFjJdQ2ZpXVrGSFVar3BiAWhcs56wuK6yFQqUzq3OslVKG62JKzje5q-C_e4ydXLqosWlUi76PkvEhWHA-gPkG1MHHGNDKVXBLFdYyAzlalAs5WpSjRQlcDhaHpdNtel8v0fytbLUNwNkWUFGrxobBjIt_3PjSeMKUXG04HFz8OAwyaoetRuMC6k4a7_674xcSr5Fw</recordid><startdate>20060201</startdate><enddate>20060201</enddate><creator>Haddow, James E.</creator><creator>McClain, Monica R.</creator><creator>Palomaki, Glenn E.</creator><creator>Kloza, Edward M.</creator><creator>Williams, Josephine</creator><general>Mosby, Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20060201</creationdate><title>Screening for thyroid disorders during pregnancy: Results of a survey in Maine</title><author>Haddow, James E. ; McClain, Monica R. ; Palomaki, Glenn E. ; Kloza, Edward M. ; Williams, Josephine</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c384t-8dcd0680716347509fb79fa6563fca2dd00bc36276b59eb8aeac1fc2ebaaad7c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Biological and medical sciences</topic><topic>Endocrinopathies</topic><topic>Family Practice - statistics & numerical data</topic><topic>Female</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Health Care Surveys</topic><topic>Humans</topic><topic>Maine</topic><topic>Mass Screening - utilization</topic><topic>Medical sciences</topic><topic>Non tumoral diseases. Target tissue resistance. Benign neoplasms</topic><topic>Obstetrics - statistics & numerical data</topic><topic>Practice Patterns, Physicians</topic><topic>Pregnancy</topic><topic>Pregnancy Complications - diagnosis</topic><topic>Prenatal Care - statistics & numerical data</topic><topic>Reference ranges</topic><topic>Reference Values</topic><topic>Thyroid Diseases - diagnosis</topic><topic>Thyroid testing</topic><topic>Thyroid. Thyroid axis (diseases)</topic><topic>Thyrotropin - blood</topic><topic>TSH</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Haddow, James E.</creatorcontrib><creatorcontrib>McClain, Monica R.</creatorcontrib><creatorcontrib>Palomaki, Glenn E.</creatorcontrib><creatorcontrib>Kloza, Edward M.</creatorcontrib><creatorcontrib>Williams, Josephine</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of obstetrics and gynecology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Haddow, James E.</au><au>McClain, Monica R.</au><au>Palomaki, Glenn E.</au><au>Kloza, Edward M.</au><au>Williams, Josephine</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Screening for thyroid disorders during pregnancy: Results of a survey in Maine</atitle><jtitle>American journal of obstetrics and gynecology</jtitle><addtitle>Am J Obstet Gynecol</addtitle><date>2006-02-01</date><risdate>2006</risdate><volume>194</volume><issue>2</issue><spage>471</spage><epage>474</epage><pages>471-474</pages><issn>0002-9378</issn><eissn>1097-6868</eissn><coden>AJOGAH</coden><abstract>Guidelines regarding prenatal screening for thyroid deficiency are conflicting, and current practice in primary care settings is unknown. Our survey sought to determine the: 1) extent of screening in Maine; 2) factors associated with screening; and 3) laboratory cut-off levels used.
In 2004 we surveyed 61 prenatal care practices, representing 246 practitioners and 85% of Maine deliveries.
Screening via thyroid-stimulating hormone (TSH) testing was routine in 48% of the practices. Obstetrician practices screened at a significantly higher rate than family practices (56% vs 8%; odds ratio [OR] 15.0, 95% CI 1.9-130.0). Nonsignificant higher rates were found for urban versus rural, and multipractitioner versus solo practices. The lower TSH cut-off levels ranged between 0.1 and 0.5 mU/L among practices; the upper cut-off levels ranged between 3.5 and 5.5 mU/L.
Prenatal screening for thyroid deficiency varies among practices, reflecting conflicting guidelines. TSH cut-offs are also variable and might benefit from standardization.</abstract><cop>Philadelphia, PA</cop><pub>Mosby, Inc</pub><pmid>16458648</pmid><doi>10.1016/j.ajog.2005.07.055</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-9378 |
ispartof | American journal of obstetrics and gynecology, 2006-02, Vol.194 (2), p.471-474 |
issn | 0002-9378 1097-6868 |
language | eng |
recordid | cdi_proquest_miscellaneous_67634877 |
source | ScienceDirect Journals |
subjects | Biological and medical sciences Endocrinopathies Family Practice - statistics & numerical data Female Gynecology. Andrology. Obstetrics Health Care Surveys Humans Maine Mass Screening - utilization Medical sciences Non tumoral diseases. Target tissue resistance. Benign neoplasms Obstetrics - statistics & numerical data Practice Patterns, Physicians Pregnancy Pregnancy Complications - diagnosis Prenatal Care - statistics & numerical data Reference ranges Reference Values Thyroid Diseases - diagnosis Thyroid testing Thyroid. Thyroid axis (diseases) Thyrotropin - blood TSH |
title | Screening for thyroid disorders during pregnancy: Results of a survey in Maine |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T11%3A15%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Screening%20for%20thyroid%20disorders%20during%20pregnancy:%20Results%20of%20a%20survey%20in%20Maine&rft.jtitle=American%20journal%20of%20obstetrics%20and%20gynecology&rft.au=Haddow,%20James%20E.&rft.date=2006-02-01&rft.volume=194&rft.issue=2&rft.spage=471&rft.epage=474&rft.pages=471-474&rft.issn=0002-9378&rft.eissn=1097-6868&rft.coden=AJOGAH&rft_id=info:doi/10.1016/j.ajog.2005.07.055&rft_dat=%3Cproquest_cross%3E67634877%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c384t-8dcd0680716347509fb79fa6563fca2dd00bc36276b59eb8aeac1fc2ebaaad7c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=67634877&rft_id=info:pmid/16458648&rfr_iscdi=true |